Helicobacter pylori
Helicobacter pylori
Overview
Helicobacter pylori is a spiral-shaped, urease-positive bacterium that colonizes the human stomach and is adapted to survive the acidic gastric environment. It is a major cause of chronic gastritis and peptic ulcer disease and is widely recognized as an important risk factor for gastric cancer. Its persistence in the gastric mucosa is supported by virulence mechanisms that promote colonization, inflammation, and tissue injury, making it a clinically significant infectious target in gastroenterology and infectious disease research.
A central biological feature of H. pylori is urease activity, which helps neutralize gastric acid and supports bacterial survival. In addition to direct pathogenic effects, infection can alter gastric mucosal homeostasis and contribute to long-term disease risk. Because eradication can reduce downstream complications, H. pylori remains a major focus of diagnostic innovation, antimicrobial regimen optimization, and studies of host–microbe interactions, including work on gastric cancer prevention and other systemic outcomes.
Focus of Latest Publications
Recent publications on Helicobacter pylori have focused on its pathogenic behavior in host tissues, its role in disease prevention and treatment, and new approaches to local eradication. One study used a three-dimensional bioartificial liver model built with radial-flow bioreactor technology to test whether H. pylori can infect hepatocytes. The bacterium was shown to adhere to hepatocyte surfaces and penetrate intercellular spaces, and infection increased apoptosis about threefold while upregulating TNF-α and activating NF-κB. The same model showed reduced PCNA expression, enhanced Akt activation, and predominantly cytoplasmic β-catenin localization, suggesting that H. pylori may exert direct pathological effects on liver cells.
Several recent studies have examined strategies to control H. pylori infection and its consequences. A polyphenol-rich extract from sea buckthorn leaves was reported to inhibit H. pylori virulence, with activity against multidrug-resistant strains and marked suppression of motility and urease activity. In infected mice, the extract reduced gastric pro-inflammatory cytokines and promoted mucosal protection, while multiomics analysis suggested increased mucosal immunity and enrichment of beneficial gastric microbiota such as Ligilactobacillus and Akkermansia. In another local-therapy approach, polydopamine-functionalized, clarithromycin-loaded nanoparticles were designed for sequential delivery in H. pylori-infected gastric ulcers; these particles showed improved mucus penetration, strong adhesion at the infection site, deep tissue penetration in mice, and nearly complete bacterial reduction with accelerated ulcer healing at a much lower antibiotic dose than conventional systemic therapy.
Additional publications addressed antimicrobial compounds and treatment outcomes. Marine-derived bisabolane-type sesquiterpenes from Aspergillus sp. WHUF04-170 showed moderate in vitro activity against both standard and multidrug-resistant H. pylori strains, and one study compared high-dose dual therapy regimens for first-line eradication. A separate publication summarized evidence that H. pylori treatment reduces gastric cancer risk across all ages. Another study found that H. pylori eradication was associated with a protective effect against osteoporosis progression in females over a 20-year prospective observational cohort, linking eradication therapy to broader systemic outcomes beyond the stomach.
Finally, one publication evaluated TCGA tumor microbiota data and found that detection of H. pylori was less reliable than for some other microbes, highlighting the need for careful validation in host-microbe association studies. Together, these reports emphasize H. pylori as a target in infection biology, gastric disease management, and broader disease-risk research, while also underscoring the importance of improved delivery systems, natural-product-based anti-virulence strategies, and rigorous data interpretation.